Science
Dana-Farber Cancer Institute Boston Children's Hospital
Dana-Farber Cancer Institute /LinkedIn

Dana-Farber Lank Center for GU Oncology Research Digest for the week of February 15 – 21

Dana-Farber Lank Center for Genitourinary Oncology shared a post on X:

“GU Research Digest for the week of February 15 – 21: a selection of publications about GU cancers in high-impact journals. Search the PMIDs on PubMed to read!”

Genitourinary/Immunotherapy/General

“Treatment strategies in human papillomavirus-related advanced penile cancer”

Authors: Mattia Longoni et al.

Dana-Farber Lank Center for GU Oncology Research Digest for the week of February 15 - 21

Renal

“Immune checkpoint inhibitors plus debulking surgery for patients with metastatic renal cell carcinoma: clinical outcomes and immunological correlates of a prospective pilot trial”

Authors: Sangeeta Goswami et al.

Dana-Farber Lank Center for GU Oncology Research Digest for the week of February 15 - 21

Bladder/Urothelial

“Predicting immunotherapy response of advanced bladder cancer through a meta-analysis of six independent cohorts”

Authors: Lilian Marie Boll et al.

Dana-Farber Lank Center for GU Oncology Research Digest for the week of February 15 - 21

“COSMIC-021 Phase Ib Study of Cabozantinib Plus Atezolizumab: Results from the Locally Advanced or Metastatic Urothelial Carcinoma Cohorts”

Authors: Sumanta Pal et al.

Dana-Farber Lank Center for GU Oncology Research Digest for the week of February 15 - 21

“Asparagine drives immune evasion in bladder cancer via RIG-I stability and type I IFN signaling”

Authors: Wenjie Wei et al.

Dana-Farber Lank Center for GU Oncology Research Digest for the week of February 15 - 21

“Bladder Preservation with Durvalumab plus Tremelimumab and Concurrent Radiotherapy in Patients with Localized Muscle-Invasive Bladder Cancer (IMMUNOPRESERVE): A Phase II Spanish Oncology GenitoUrinary Group Trial”

Authors: Xavier Garcia-Del-Muro et al.

Dana-Farber Lank Center for GU Oncology Research Digest for the week of February 15 - 21

Prostate

“Engineering nanozyme immunomodulator with magnetic targeting effect for cascade-enzyodynamic and ultrasound-reinforced metallo-immunotherapy in prostate carcinoma”

Authors: Yandong Wang et al.

Dana-Farber Lank Center for GU Oncology Research Digest for the week of February 15 - 21

“Predicting dose response to prostate cancer radiotherapy: validation of a radiation signature in the randomized phase III NRG/RTOG 0126 and SAKK 09/10 trials”

Authors: A Dal Pra et al.

Dana-Farber Lank Center for GU Oncology Research Digest for the week of February 15 - 21

“EZH1/EZH2 inhibition enhances adoptive T cell immunotherapy against multiple cancer models”

Authors: Patrizia Porazzi et al.

Dana-Farber Lank Center for GU Oncology Research Digest for the week of February 15 - 21

“Validation of a digital pathology-based multimodal artificial intelligence biomarker in a prospective, real-world prostate cancer cohort treated with prostatectomy”

Authors: Anders Bjartell et al.

Dana-Farber Lank Center for GU Oncology Research Digest for the week of February 15 - 21

“Integrating the environmental and genetic architectures of aging and mortality”

Authors: Austin Argentieri et al.

Dana-Farber Lank Center for GU Oncology Research Digest for the week of February 15 - 21

“Assessing the contribution of rare protein-coding germline variants to prostate cancer risk and severity in 37,184 cases”

Authors: Jonathan Mitchell et al.

Dana-Farber Lank Center for GU Oncology Research Digest for the week of February 15 - 21

“Tumour-wide RNA splicing aberrations generate actionable public neoantigens”

Authors: Darwin Kwok et al.

Dana-Farber Lank Center for GU Oncology Research Digest for the week of February 15 - 21

“Clinical and Translational Results from PORTER, a Multi-cohort Phase 1 Platform Trial of Combination Immunotherapy in Metastatic Castration-Resistant Prostate Cancer”

Authors: Matthew Galsky et al.

Dana-Farber Lank Center for GU Oncology Research Digest for the week of February 15 - 21

More posts featuring Dana-Farber Lank Center for Genitourinary Oncology.

Anders Bjartell Austin Argentieri bladder cancer cancer Dal Pra Dana-Farber Lank Center for Genitourinary Oncology Darwin Kwok human papillomavirus Jonathan Mitchell Lilian Marie Boll Matthew Galsky Mattia Longoni OncoDaily Oncology Patrizia Porazzi prostate cancer renal cell carcinoma Research Digest Sangeeta Goswami Sumanta Pal Wenjie Wei Xavier Garcia-del-Muro Yandong Wang